These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21255266)

  • 1. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder.
    Stergiakouli E; Langley K; Williams H; Walters J; Williams NM; Suren S; Giegling I; Wilkinson LS; Owen MJ; O'Donovan MC; Rujescu D; Thapar A; Davies W
    Genes Brain Behav; 2011 Apr; 10(3):334-44. PubMed ID: 21255266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic variant within
    Humby T; Fisher A; Allen C; Reynolds M; Hartman A; Giegling I; Rujescu D; Davies W
    Brain Behav; 2017 Mar; 7(3):e00646. PubMed ID: 28293481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder.
    Brookes KJ; Hawi Z; Kirley A; Barry E; Gill M; Kent L
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1531-5. PubMed ID: 18937300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity disorder and influence brain tissue mRNA expression.
    Brookes KJ; Hawi Z; Park J; Scott S; Gill M; Kent L
    Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1417-24. PubMed ID: 20862695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits.
    Kent L; Emerton J; Bhadravathi V; Weisblatt E; Pasco G; Willatt LR; McMahon R; Yates JR
    J Med Genet; 2008 Aug; 45(8):519-24. PubMed ID: 18413370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation.
    Wang LJ; Chan WC; Chou MC; Chou WJ; Lee MJ; Lee SY; Lin PY; Yang YH; Yen CF
    Sci Rep; 2017 Apr; 7():45595. PubMed ID: 28367959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairments are different in single-incidence and multi-incidence ADHD families.
    Oerlemans AM; Hartman CA; de Bruijn YGE; Franke B; Buitelaar JK; Rommelse NNJ
    J Child Psychol Psychiatry; 2015 Jul; 56(7):782-791. PubMed ID: 25346282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked ichthyosis associated with psychosis and behavioral abnormalities: a case report.
    Malik A; Amer AB; Salama M; Haddad B; Alrifai MT; Balwi MA; Davies W; Eyaid W
    J Med Case Rep; 2017 Sep; 11(1):267. PubMed ID: 28934990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population.
    Riglin L; Collishaw S; Thapar AK; Dalsgaard S; Langley K; Smith GD; Stergiakouli E; Maughan B; O'Donovan MC; Thapar A
    JAMA Psychiatry; 2016 Dec; 73(12):1285-1292. PubMed ID: 27806167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice.
    Trent S; Cassano T; Bedse G; Ojarikre OA; Humby T; Davies W
    Neuropsychopharmacology; 2012 Apr; 37(5):1267-74. PubMed ID: 22189290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ASTN2 variants in childhood and adult ADHD, comorbid disorders and associated personality traits.
    Freitag CM; Lempp T; Nguyen TT; Jacob CP; Weissflog L; Romanos M; Renner TJ; Walitza S; Warnke A; Rujescu D; Lesch KP; Reif A
    J Neural Transm (Vienna); 2016 Aug; 123(8):849-58. PubMed ID: 27138430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention.
    Davies W; Humby T; Kong W; Otter T; Burgoyne PS; Wilkinson LS
    Biol Psychiatry; 2009 Aug; 66(4):360-7. PubMed ID: 19251250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis.
    Williams NM; Zaharieva I; Martin A; Langley K; Mantripragada K; Fossdal R; Stefansson H; Stefansson K; Magnusson P; Gudmundsson OO; Gustafsson O; Holmans P; Owen MJ; O'Donovan M; Thapar A
    Lancet; 2010 Oct; 376(9750):1401-8. PubMed ID: 20888040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD.
    Davies W; Humby T; Trent S; Eddy JB; Ojarikre OA; Wilkinson LS
    Neuropsychopharmacology; 2014 Oct; 39(11):2622-32. PubMed ID: 24842408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric Polygenic Risk Scores as Predictor for Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in a Clinical Child and Adolescent Sample.
    Jansen AG; Dieleman GC; Jansen PR; Verhulst FC; Posthuma D; Polderman TJC
    Behav Genet; 2020 Jul; 50(4):203-212. PubMed ID: 31346826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD.
    Smoller JW; Biederman J; Arbeitman L; Doyle AE; Fagerness J; Perlis RH; Sklar P; Faraone SV
    Biol Psychiatry; 2006 Mar; 59(5):460-7. PubMed ID: 16197923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support for association between ADHD and two candidate genes: NET1 and DRD1.
    Bobb AJ; Addington AM; Sidransky E; Gornick MC; Lerch JP; Greenstein DK; Clasen LS; Sharp WS; Inoff-Germain G; Wavrant-De Vrièze F; Arcos-Burgos M; Straub RE; Hardy JA; Castellanos FX; Rapoport JL
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):67-72. PubMed ID: 15717291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.
    Merker S; Reif A; Ziegler GC; Weber H; Mayer U; Ehlis AC; Conzelmann A; Johansson S; Müller-Reible C; Nanda I; Haaf T; Ullmann R; Romanos M; Fallgatter AJ; Pauli P; Strekalova T; Jansch C; Vasquez AA; Haavik J; Ribasés M; Ramos-Quiroga JA; Buitelaar JK; Franke B; Lesch KP
    J Child Psychol Psychiatry; 2017 Jul; 58(7):798-809. PubMed ID: 28224622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KTN1 variants and risk for attention deficit hyperactivity disorder.
    Luo X; Guo X; Tan Y; Zhang Y; Garcia-Milian R; Wang Z; Shi J; Yu T; Ji J; Wang X; Xu J; Zhang H; Zuo L; Lu L; Wang K; Li CR
    Am J Med Genet B Neuropsychiatr Genet; 2020 Jun; 183(4):234-244. PubMed ID: 32190980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype.
    Bellgrove MA; Hawi Z; Gill M; Robertson IH
    Cortex; 2006 Aug; 42(6):838-45. PubMed ID: 17131588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.